In April, Wojcicki notified the company of her intention to make an offer and take the company private. Genetic testing firm 23andMe will not go ahead with CEO Anne Wojcicki’s take-private offer and has asked her to withdraw any plan to oppose an alternative deal, the company said on Friday.